Vera Therapeutics (VERA) Shares Issued (2021 - 2026)

Vera Therapeutics' Shares Issued history runs 6 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• Quarterly Shares Issued rose 60.31% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 60.31% YoY) and the FY2025 annual result came in at $8.4 million, up 26.97% from the prior year.
• Shares Issued was $4.1 million for Q1 2026 at Vera Therapeutics, down from $8.4 million in the prior quarter.
• Across five years, Shares Issued topped out at $8.4 million in Q4 2025 and bottomed at $261306.0 in Q2 2023.
• A 5-year average of $2.5 million and a median of $2.0 million in 2025 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2022 — Shares Issued jumped 172.38% — and 2023, when it tumbled 93.12%.
• Vera Therapeutics' Shares Issued stood at $3.8 million in 2022, then plunged by 31.66% to $2.6 million in 2023, then surged by 153.16% to $6.6 million in 2024, then gained by 26.97% to $8.4 million in 2025, then tumbled by 51.55% to $4.1 million in 2026.
• Business Quant data shows VERA's Shares Issued at $4.1 million in Q1 2026, $8.4 million in Q4 2025, and $1.4 million in Q3 2025.